Metabolomic studies of human lung carcinoma cell lines using in vitro 1H NMR of whole cells and cellular extracts

NMR in Biomedicine

Volumn 21, Issue 8, 2008, Pages 809-819

  Gottschalk, M ^a   Ivanova, G ^a,b   Collins, D M ^a   Eustace, A ^a   O'Connor, R ^a   Brougham, Dermot F ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b INSTITUTE OF ORGANIC CHEMISTRY   (Bulgaria)

Author keywords

Human; Lung cancer; Metabolomic study; Multidrug resistance; Principal component analysis

Indexed keywords

CELL CULTURE;

HUMAN; LUNG CANCER; METABOLOMIC STUDY; MULTIDRUG RESISTANCE;

PRINCIPAL COMPONENT ANALYSIS;

CARBENE; CHOLINE; WATER;

ARTICLE; CANCER RESISTANCE; CANCER SCINTISCANNING; CARCINOMA CELL; CELL METABOLISM; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LUNG CARCINOMA; METABOLITE; METABOLOMICS; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE STUDY; SPECTRAL SENSITIVITY; WHOLE CELL;

CELL EXTRACTS; CELL LINE, TUMOR; CHOLINE; HUMANS; LIPID METABOLISM; LUNG NEOPLASMS; MAGNETIC RESONANCE SPECTROSCOPY; PROTONS;

EID: 53849135245     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1258     Document Type: Article

References (56)

1. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat. Rev. Cancer. 2005; 5: 275-284.
2. Fan D, Beltran PJ, O'Brien CA. Reversal of multidrug resistance. In Reversal of Multidrug Resistance in Cancer, JA Kellen (ed). CRC Press: Boca Raton, FL, 1994; 93-124.
3. Krishna R, Mayer LD. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur. J. Pharm. Sci. 2000; 11: 265-283.
4. Ferte J. Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane. Eur J. Biochem. 2000; 267: 277-294.
5. Borst P, Zelcer N, van Helvoort A. ABC transporters in lipid transport. Biochim. Biophys. Acta 2000; 1486: 128-144.
6. Hipfner DR, Deeley RG, Cole SPC. Structural, mechanistic and clinical aspects of MRP1. Biochim. Biophys. Acta 1999; 1461: 359-376.
7. Dean M, Rzhetsky A, Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 2001; 11: 1156-1166.
8. Cole SP, Deeley RG. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP. Bioessays 1998; 20: 931-940.
9. Leslie EM, Deeley RG, Cole SP. Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology 2001; 167: 3-23.
10. 1H magnetic resonance spectroscopy: a pilot study. Magn Reson. Imaging 2004; 22: 697-706.
11. 1H NMR spectroscopy. NMR Biomed. 2006; 19: 90-100.
12. 1H NMR spectroscopic investigation. NMR Biomed. 2005; 18: 371-382.
13. Jordan BF, Black K, Robey IF, Runquist M, Powis G, Gillies RJ. Metabolite changes in HT-29 xenograft tumors following HIF-1α inhibition with PX-478 as studied by MR spectroscopy in vivo and ex vivo. NMR Biomed. 2005; 18: 430-439.
14. Bollard ME, Stanley EG, Lindon JC, Nicholson JK, Holmes E. NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed. 2005; 18: 143-162.
15. 1H NMR study of human high grade gliomas. NMR Biomed. 2004; 17: 191-205.
16. 1H NMR spectroscopy. NMR Biomed. 2002; 15: 375-384.
17. 31P MR spectroscopy of primary and recurrent human brain tumors in vitro: malignancy-characteristic profiles of water soluble and lipophilic spectral components. NMR Biomed. 2001; 14: 307-317.
18. 1H NMR studies. Chem.-Biol. Interact. 2005; 151: 83-94.
19. Le Moyec L, Legrand O, Larue V, Kawakami M, Marie JP, Calvo F, Hantz E, Taillandier E. Magnetic resonance spectroscopy of cellular lipid extracts from sensitive, resistant and reverting K562 cells and flow cytometry for investigating the P-glycoprotein function in resistance reversion. NMR Biomed. 2000; 13: 92-101.
20. 1H NMR mobile lipid and cholesterol in two human tumor multidrug resistant cell lines (MCF-7 and LoVo). Biochim. Biophys. Acta 2001; 1531: 111-131.
21. 1H NMR spectroscopy and phosphatidylserine externalisation. Anticancer Res. 2001; 21: 3915-3920.
22. Bloom M, Holmes KT, Mountford CE, Williams PG. Complete proton magnetic resonance in whole cells. J. Magn. Reson. 1986; 69: 73-91.23.
23. Le Moyec L, Tatoud R, Eugene M, Gauville C, Primot I, Charlemagne D, Calvo F. Cell and membrane lipid analysis by proton magnetic resonance spectroscopy in five breast cancer cell lines. Br. J. Cancer 1992; 66: 623-628.
24. Le Moyec L, Tatoud R, Degeorges A, Calabresse C, Bauza G, Eugene M, Calvo F. Proton nuclear magnetic resonance spectrscopy reveals cellular lipids involved in resistance to adriamycin and taxol by K562 leukemia cell line. Cancer Res. 1996; 56: 3461-3467.
25. 1H NMR-visible mobile lipid domains correlate with cytoplasmic lipid bodies in apoptotic T-lymphoblastoid cells. Biochim. Biophys. Acta 2001; 1530: 47-66.
26. 1H nuclear magnetic resonance visible polyunsaturated fatty acids in BT4C gliomas undergoing ganciclovir-thymidine kinase gene therapy-iduced programmed cell death. Cancer Res. 2003; 63: 3195-3201.
27. 1H-NMR spectroscopy. NMR Biomed. 2002; 15: 37-44.
28. Waters NJ, Holmes E, Waterfield CJ, Farrant RD, Nicholson JK. NMR and pattern recognition studies on liver extracts and intact livers from rats treated with α-naphthylisothiocyanate. Biochem. Pharmacol. 2002; 64: 67-77.
29. Maharjan RP, Ferenci T. Global metabolite analysis: the influence of extraction methodology on metabolome profiles of Escherichia coli. Anal. Biochem. 2003; 313: 145-154.
30. 1H-NMR spectroscopy and self-organizing maps. NMR Biomed. 2003; 16: 1-11.
31. 1H NMR of tissue extracts in SIV-infected macaques. NMR Biomed. 2005; 18: 242-251.
32. Spraul M, Neidig P, Klauck U, Kessler P, Holmes E, Nicholson JK, Sweatman BC, Salman SR, Farrant RD, Rahr E, Beddell CR, Lindon JC. Automatic reduction of NMR spectroscopic data for statistical and pattern recognition classifications of samples. Pharm. Biomed. Anal. 1994; 12: 1215-1225.
33. Lindon JC, Holmes E, Nicholson JK. Pattern recognition methods and applications in biomedical magnetic resonance. Prog. NMR Spectr. 2001; 39: 1-40.
34. Griffin JL. Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterization of xenobiotic toxicity and disease diagnosis. Curr. Opin. Chem. Biol. 2003; 7: 648-654.
35. Wang Y, Holmes E, Nicholson JK, Cloarec O, Chollet J, Tanner M, Singer BH, Utzinger J. Metabonomic investigations in mice infected with Schistosoma mansoni: An approach for biomarker identification. Proc. Natl. Acad. Sci. USA 2004; 101: 12676-12681.
36. Bollard ME, Stanley EG, Lindon JC, Nicholson JK, Holmes E. NMR-based metabonomic approaches for evaluating physiological influences on biofluids composition. NMR Biomed. 2005; 18: 143-162.
37. Law E, Gilvarry U, Lynch V, Gregory B, Grant G, Clynes M. Cytogenetic comparison of two poorly differentiated human lung squamous cell carcinoma lines. Cancer Genet. Cytogenet. 1992; 59: 111-118.
38. Duffy CP, Elliott CJ, O'Connor RA, Heenan MM, Coyle S, Cleary IM, Kavanagh K, Verhaegen S, O'Loughlin CM, NicAmhlaoibh R, Clynes M. Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs). Eur. J. Cancer 1998; 34: 1250-1259.
39. Heenan M, O'Driscoll L, Cleary I, Connolly L, Clynes M. Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance. Int. J. Cancer 1997; 71: 907-915.
40. O'Loughlin C, Heenan M, Coyle S, Clynes M. Altered cell cycle response of drug-resistant lung carcinoma cells to doxorubicin. Eur. J. Cancer 2000; 36: 1149-1160.
41. Tate AR, Underwood J, Acosta DM, Julià-Sapé M, Majós C, Moreno-Torres A, Howe FA, van der Graaf M, Lefournier V, Murphy MM, Loosemore A, Ladroue C, Wesseling P, Bosson JL, Cabañas ME, Simonetti AW, Gajewicz W, Calvar J, Capevila A, Wilkins PR, Bell BA, Rémy C, Heerschap A, Watson D, Griffiths JR, Arus C. Development of a decision support system for diagnostics and grading of brain tumours using in vivo magnetic resonance single voxel spectra. NMR Biomed. 2006; 19: 411-434.
42. Berger S, Braun S. 200 and more basic NMR experiments: a practical course. Wiley-VCH: Weinheim, 2004.
43. 1H NMR spectroscopy. J. Magn. Reson. B. 1994; 104: 1-10.
44. Bax A, Davis DG. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 1985; 65: 355-360.
45. Jackson JE. A User's Guide to Principal Components. Wiley-Interscience: Hoboken, NJ, 2003.
46. Wold S. Cross-validatory estimation of the number of components in factor and principal component models. Technometrics 1978; 20: 397-405.
47. Krzanowski WJ. Cross-validation in principal analysis. Biometrics 1987; 43: 575-584.
48. Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 2000; 13: 129-153.
49. Hanaoka H, Yoshioka Y, Ito I, Niito K, Yasuda N. In vitro characterization of lung cancers by the use of 1-H nuclear magnetic resonance spectroscopy of tissue extracts and discriminant factor analysis. Magn. Reson. Med. 1993; 29: 436-440.
50. 1H NMR metabonomics to breast cancer characterisation and detection. Progress in NMR Spectroscopy 2005; 47: 165-174.
51. 13C NMR of virgin olive oil. An overview. Magn. Reson. Chem. 1997; 35: S133-S145.
52. Field FJ, Born E, Chen H, Murphy S, Mathur SN. Esterification of plasma membrane cholesterol and triacyl glycerol-rich lipoprotein secretion in CaCo-2 cells: possible role of p-glycoprotein. J. Lipids Res. 1995; 36: 1533-1543.
53. Bhattacharya S, Haldar S. The effect of cholesterol inclusion on the vesicular membranes of cationic lipids. Biochim. Biophys. Acta 1996; 1283: 21-30.
54. Batetta B, Pani A, Putzolo M, Sanna F, Bonatesta R, Piras S, Spano O, Mulas MF, Dessi S. Correlation between cholesterol esterification, MDR1 gene expression and rate of cell proliferation in CEM and MOLT4 cell lines. Cell Prolif. 1999; 32: 49-61.
55. Demant EJ, Schested M, Jensen PB. A model for computer simulation of P-glycoprotein and transmembrane delta pH-mediated antracycline transport in multidrug-resistant tumor cells. Biochim. Biophys. Acta. 1990; 1055: 117-125.
56. Le Moyec L, Kawakami M, Leray G, Larue V, Briane D, Hantz E, De Certaines J. Magnetic resonance spectroscopy and fluorescence microscopy to investigate mobile lipids in sensitive, resistant and reverting K562 cells and their membranes. Anticancer Res. 2000; 20: 4513-4518.